Printer Friendly

Browse Ovarian cancer topic

Drug therapy subtopic

Articles

1-172 out of 172 article(s)
Title Author Type Date Words
FDA Approves Drug for Women with Breast Cancer Caused by BRCA, the 'Jewish Gene'. Feb 19, 2018 324
JHL Biotech submits clinical trial application to Bulgarian Drug Agency for proposed bevacizumab biosimilar for multiple cancers. Dec 21, 2017 169
CHMP Refers Rucaparib MAA for Ovarian Cancer Treatment Indication to Scientific Advisory Group on Oncology for Review. Dec 20, 2017 359
FDA reviews Roche's Avastin as first-line treatment for ovarian cancer. Oct 27, 2017 227
FDA reviews Roche's Avastin as first-line treatment for ovarian cancer. Oct 27, 2017 223
DelMar Pharmaceuticals Presents Poster at AACR's Ovarian Cancer Special Conference on the Mechanistic Rationale for VAL-083 Overcoming Treatment Resistance in Ovarian Cancer. Conference news Oct 3, 2017 1589
DelMar Pharmaceuticals to begin clinical trials of VAL-083 for the treatment of ovarian cancer upon US FDA clearance. Sep 19, 2017 298
DelMar Pharmaceuticals to begin clinical trials of VAL-083 for the treatment of ovarian cancer upon US FDA clearance. Sep 19, 2017 294
DelMar Pharmaceuticals Receives IND Allowance from FDA to Initiate Clinical Trials of VAL-083 for the Treatment of Ovarian Cancer. Sep 18, 2017 1608
TapImmune Amends Phase 2 Clinical Trial to Focus on Larger Population of Women with Platinum-Sensitive Ovarian Cancer with Greatest Unmet Need for New Treatments. Aug 8, 2017 782
Targeted treatment for ovarian cancer shows promising results in early trials. Jun 5, 2017 263
Targeted treatment for ovarian cancer shows promising results in early trials. Jun 5, 2017 259
New drug shrinks cancers in study. Jun 3, 2017 125
OncoQuest to Present Oregovomab Phase II Interim Clinical Results for Front Line Treatment of Ovarian Cancer at the American Society of Clinical Oncology (ASCO) Annual Meeting. Clinical report May 24, 2017 1512
OncoQuest to Present Oregovomab Phase II Interim Clinical Results for Front Line Treatment of Ovarian Cancer at the American Society of Clinical Oncology (ASCO) Annual Meeting. Clinical report May 24, 2017 1419
Clinigen Group collaborates with Tesaro for ovarian cancer drug. May 15, 2017 160
Clinigen Group collaborates with Tesaro for ovarian cancer drug. May 15, 2017 156
OncoQuest Announces Enrollment of First Patient in Phase 1/2 Clinical Study Using Combination of Oregovomab with Checkpoint Inhibitor Nivolumab in Recurrent Ovarian Cancer. Clinical report May 9, 2017 1191
TESARO wins US FDA approval for ZEJULA for the treatment of women with recurrent ovarian cancer. Mar 28, 2017 280
TESARO wins US FDA approval for ZEJULA for the treatment of women with recurrent ovarian cancer. Mar 28, 2017 276
United States : ImmunoGen to present preclinical data highlighting potential of combining Mirvetuximab Soravtansine with an Immune Checkpoint Inhibitor at SITC 2016 Annual Meeting. Nov 12, 2016 323
United States : Cumberland Pharmaceuticals Launches Promotion Of Ethyol In The United States For Oncology Patient Support. Sep 27, 2016 360
Cumberland Pharmaceuticals Launches Promotion Of Ethyol In The United States For Oncology Patient Support. Sep 26, 2016 1118
TESARO wins US FDA fast track designation for niraparib for recurrent ovarian cancer. Sep 13, 2016 189
TESARO wins US FDA fast track designation for niraparib for recurrent ovarian cancer. Sep 13, 2016 185
DelMar Pharmaceuticals Presents Data Supporting the Potential of VAL-083 as a New Treatment for Ovarian Cancer at the 11th Biennial Ovarian Cancer Research Symposium. Sep 13, 2016 1567
Australia,United States : NOVOGEN to start human studies for its ovarian cancer drug with US FDA nods. Sep 13, 2016 173
United States : Cumberland Pharmaceuticals Begins U.S. Shipments Of Ethyol (amifostine) For Oncology Patient Support. Aug 29, 2016 336
Clovis Oncology's NDA for rucaparib accepted by US FDA for accelerated approval for advanced mutant BRCA ovarian cancer. Aug 24, 2016 215
Cerulean passes US FDA fast track designation for CRLX101to treat ovarian cancer. Jul 19, 2016 258
Cerulean passes US FDA fast track designation for CRLX101to treat ovarian cancer. Jul 19, 2016 262
Germany : Merck KGaA, Darmstadt, Germany, and Pfizer Initiate Phase III Trial to Evaluate Avelumab as First-line Treatment for Ovarian Cancer. Jul 8, 2016 400
United States : Merck and Pfizer Initiate Phase III Trial to Evaluate Avelumab as First-line Treatment for Ovarian Cancer. Jul 7, 2016 419
SELLAS Life Sciences Group Announces Initiation of Galinpepimut-S (WT1 Cancer Vaccine) Phase 1 Clinical Trial in Combination with PD-1 Checkpoint Inhibitor for Patients with Ovarian Cancer. May 2, 2016 1297
Celsion Announces Upcoming Presentation at AACR 2016 Highlighting Potential of GEN-1 IL-12 Immunotherapy in Ovarian Cancer. Apr 12, 2016 887
Aduro Biotech begins treatment of first ovarian cancer patient in combination trial of epacadostat with CRS-207. Mar 25, 2016 220
Aduro Biotech begins treatment of first ovarian cancer patient in combination trial of epacadostat with CRS-207. Mar 25, 2016 216
National Academy of Medicine Ovarian Cancer Report Ignites Reaction from Vermillion & OVA1 Awareness Team. Mar 11, 2016 1218
TapImmune Granted Fast Track Designation by U.S. Food & Drug Administration for its Lead Vaccine TPIV 200 in the Treatment of Ovarian Cancer. Feb 3, 2016 706
FDA Finally Speeds Up Approval for Ovarian Cancer Drugs. Jan 22, 2016 546
Celsion Reports Translational Research Data from its Phase 1b Study of GEN-1 Immunotherapy in Recurrent Ovarian Cancer. Jan 7, 2016 1202
U.S. Food & Drug Administration Grants Orphan Drug Designation to TapImmune's TPIV 200 in the Treatment of Ovarian Cancer. Dec 9, 2015 735
EMA Grants Orphan Drug Designation to Debiopharm International SA's IAP Inhibitor Debio 1143 in the Treatment of Ovarian Cancer. Dec 8, 2015 471
EMA Grants Orphan Drug Designation to Debiopharm International SA's IAP Inhibitor Debio 1143 in the Treatment of Ovarian Cancer. Dec 8, 2015 476
Over 50% of Ovarian Cancer Treatment Pipeline Products Are First-in-Class, Says GBI Research. Dec 8, 2015 717
Over 50% of Ovarian Cancer Treatment Pipeline Products Are First-in-Class, Says GBI Research. Dec 8, 2015 722
DelMar Pharmaceuticals Presents Positive Preclinical Data on VAL-083 as a Promising Treatment for Ovarian Cancer. Oct 19, 2015 2202
Rx for change: oncologists avoid using the best treatment for ovarian cancer. Massion, Charlea T.; Fugh-Berman, Adrianne Sep 1, 2015 1344
Proteins may boost ovarian cancer drugs. Aug 25, 2015 103
Ovarian Cancer Treatment Drugs Markets in China. Aug 5, 2015 420
Ovarian Cancer Drug Pathway Analyzer 2015. Jun 23, 2015 1214
Celsion Expands Clinical Development Plan for GEN-1 IL-12 Immunotherapy Program in Ovarian Cancer. Apr 29, 2015 1469
VentiRx Pharmaceuticals Granted Orphan Drug Designation in the European Union For Motolimod in the Treatment of Ovarian Cancer. Apr 27, 2015 812
The synergistic effect of thymoquinone and epigallocatechin-3-gallate on the functional capacity of Caov-3 ovarian cancer like cell line. Harpole, Jennifer L.; Tucci, Michelle; Benghuzzi, Hamed Report Apr 1, 2015 1917
Oncolytics Biotech receives EMA Orphan Drug Designation for treatment of ovarian cancer. Mar 25, 2015 222
Oncolytics Biotech receives EMA Orphan Drug Designation for treatment of ovarian cancer. Mar 25, 2015 218
Celsion Corporation Presents Clinical and Preclinical Data for GEN-1 IL-12 Immunotherapy in Ovarian Cancer at the Molecular Medicine TRI-Conference. Conference news Feb 20, 2015 1281
New medication approved for treating ovarian cancer. Feb 1, 2015 150
Advances made in treatment of gynecologic cancers: however, early diagnosis still remains a challenge. Feb 1, 2015 990
FDA Grants Orphan Drug Designation to OS2966 in the Treatment of Ovarian Cancer. Jan 21, 2015 460
Celsion Corporation Submits DNA-based Immunotherapy Clinical Protocol to the FDA as Part of a First Line Treatment for Ovarian Cancer. Jan 6, 2015 1093
United States : FDA approves Lynparza to treat advanced ovarian cancer. Dec 20, 2014 468
LYNPARZA(TM) Approved By The US Food and Drug Administration For The Treatment Of Advanced Ovarian Cancer In Patients With Germline BRCA-mutations. Dec 19, 2014 1414
United Kingdom : Immunovaccine Receives FDA Fast Track Designation for DPX-Survivac for Treatment of Ovarian Cancer. Dec 12, 2014 409
The United States Food and Drug Administration approves Avastin to treat women with platinum-resistant, recurrent ovarian cancer. Nov 18, 2014 169
The United States Food and Drug Administration approves Avastin to treat women with platinum-resistant, recurrent ovarian cancer. Nov 18, 2014 167
The United States Food and Drug Administration approves Avastin to treat women with platinum-resistant, recurrent ovarian cancer. Nov 18, 2014 163
Novocure(TM) Enrolls First Patient in a Pilot Study of Tumor Treating Fields (TTFields) Together with Paclitaxel for the Treatment of Recurrent Ovarian Cancer. Oct 30, 2014 727
Novocure(TM) Enrolls First Patient in a Pilot Study of Tumor Treating Fields (TTFields) Together with Paclitaxel for the Treatment of Recurrent Ovarian Cancer. Oct 30, 2014 733
Prophylactic salpingectomy for ovarian cancer risk. Jancin, Bruce Oct 1, 2014 1267
New blood test could offer more tailored treatment of ovarian cancer. Brief article Oct 1, 2014 213
CytRx Receives Multiple FDA Orphan Drug Designations for Aldoxorubicin for the Treatment of Glioblastoma, Small Cell Lung Cancer and Ovarian Cancer. Sep 29, 2014 1507
Improved Survival of Ovarian Cancer Patients Receiving Treatment Guided by Comprehensive Tumour Profiling. Sep 11, 2014 993
VentiRx Pharmaceuticals Announces Fast Track Designation Granted for Motolimod (VTX-2337), a Novel Immunotherapy for Women with Ovarian Cancer. Sep 2, 2014 707
Roche gains European approval for Avastin ovarian cancer treatment. Aug 7, 2014 202
Roche gains European approval for Avastin ovarian cancer treatment. Aug 7, 2014 198
Intravenous Aacorbate in the Treatment of Ovarian Cancer: based on interviews with Nancy Faass. Drisko, Jeanne; Chen, qi Aug 1, 2014 3372
Ovarian Cancer Treatment Discovered. Jun 20, 2014 547
Quest PharmaTech Completes Patient Enrollment in Phase IIb Study of Oregovomab for the Immunotherapy of Ovarian Cancer. Jun 9, 2014 687
GLOBAL COLLABORATION DEVELOPES BRAIN CANCER DRUGS. Jan 1, 2014 677
Novogen Announces Establishment of Global Collaboration to Drive The Development of Drugs to Treat Brain Cancer. Dec 20, 2013 803
NOVOGEN JOINT VENTURE DEVELOPS OVARIAN CANCER DRUGS. Dec 1, 2013 777
Novogen Launches Joint Venture Aimed At Developing Drugs to Fight Ovarian Cancer. Nov 6, 2013 1070
Ovarian Cancer Drug Pathway Analyzer 2013. Oct 22, 2013 1254
New ovarian cancer treatment succeeds in the lab. Oct 16, 2013 383
Novel treatments utilize standard drugs to double "high value" response rates for patients with resistant ovarian cancer. Oct 10, 2013 653
National Ovarian Cancer Awareness Month in September Turns Rare Spotlight on Deadliest Gynecologic Cancer and Efforts to Help Improve Survival. Sep 19, 2013 961
Sorrento Therapeutics Announces a Presentation on Cynviloq(TM) at the AACR Conference on Advances in Ovarian Cancer Research: From Concept to Clinic. Conference news Sep 16, 2013 757
Meal timing may help improve fertility in women with polycystic ovaries. Aug 14, 2013 482
The Majority of Surveyed Oncologists Prescribe Avastin Off-label to Their Ovarian Cancer Patients; However Approximately Half Encounter Access and Reimbursement Hurdles. Aug 14, 2013 703
United States : Regulatory Update - GSK announces EU submission seeking additional indication for VotrientA as maintenance therapy for advanced ovarian cancer. Aug 8, 2013 106
DiaTech Oncology's MiCK test shows efficacy to guide lung, ovarian cancer treatment. Jun 20, 2013 179
Promise in treating ovarian cancer: experimental medicine uses seek-and-destroy technique. Seppa, Nathan May 18, 2013 363
ASCO 2013: Boehringer Ingelheim to Present Data Across Multiple Cancers, Including Different Treatment Settings for Advanced NSCLC. May 15, 2013 2701
New drug for low-grade ovarian cancer identified. Feb 15, 2013 285
OXiGENE combines two drugs to treat patients with recurrent ovarian cancer. Feb 8, 2013 209
OXiGENE combines two drugs to treat patients with recurrent ovarian cancer. Feb 8, 2013 205
Quest PharmaTech Enrolls 40th Patient in its Phase II Oregovomab Front-Line Chemo-Immunotherapy Clinical Trial for Ovarian Cancer in Italy and the U.S. Jan 22, 2013 724
The Ovarian Cancer Drug Market Will More Than Triple Over the Next Decade, Increasing from $460 Million in 2011 to $1.4 Billion in 2021. Dec 10, 2012 752
Common diabetes drug may treat ovarian cancer. Clinical report Dec 6, 2012 300
Common diabetes drug improves survival of ovarian cancer patients. Dec 4, 2012 350
Certain breast cancers genetically similar to ovarian tumors: findings suggest possible new treatments for breast cancer. Dec 1, 2012 614
Annai Systems And ThoughtWorks Develop Evidence Engine For The Clearity Foundation To Individualize Options For Treatment Of Ovarian Cancer. Nov 15, 2012 917
Annai Systems And Thoughtworks Develop Evidence Engine For The Clearity Foundation To Individualize Options For Treatment Of Ovarian Cancer. Nov 15, 2012 924
Japan : Anti-Cancer Agent AvastinA, Application for Approval of Additional Indication of Ovarian Cancer. Oct 6, 2012 381
Drugs for ovarian tumors may benefit people with deadly breast cancer. Sep 24, 2012 640
Adding bevacizumab to standard chemotherapy prolongs the progression-flee interval but not overall survival. Jul 1, 2012 459
Olaparib significantly increases progression-free survival in women who have platinum-sensitive, recurrent ovarian cancer. Jul 1, 2012 721
Merck collaboration focuses on ovarian cancer treatment. May 21, 2012 375
War on cancer. Moss, Ralph Apr 1, 2012 2168
Ovarian cancer drug slows disease progression. Mar 1, 2012 507
Key to understand biology and treatment of ovarian cancer identified. Disease/Disorder overview Feb 22, 2012 611
Researchers take a new look at ovarian cancer treatment. Jan 18, 2012 399
Tumor-Freezing Treatment Gives Ovarian Cancer Patients Extra Time: Presented at ISET 2012. Jan 15, 2012 413
Tiny genetic variation can predict outcome of ovarian cancer treatment. Clinical report Dec 5, 2011 398
In 2020, the Angiogenesis Inhibitor Drug Class Will Account for Nearly Half of the Ovarian Cancer Drug Market. Nov 15, 2011 764
-Oasmia completes enrolment for phase III study with ovarian cancer drug. Oct 3, 2011 183
-Oasmia completes enrolment for phase III study with ovarian cancer drug. Oct 3, 2011 174
Research and Markets: Global Ovarian Cancer Drug Pipeline Capsule - 2011 Report Will Help Executives to Keep A Track of Their Competitors and Understand Their Pipeline Molecules. Sep 27, 2011 404
Tropical plant extracts offer new hope for effective ovarian cancer therapy. Aug 26, 2011 242
Detailed genomic analysis of ovarian cancer may lead to effective treatment. Jun 30, 2011 282
PARP inhibitor delays progression in ovarian ca. Wachter, Kerri Jun 1, 2011 583
FDA Grants Orphan Drug Designation for Nektar's Investigational Drug, NKTR-102, for Treatment of Women with Ovarian Cancer. Apr 21, 2011 1319
The case of the uncontrolled nausea and vomiting. Eisenberg, Seth Apr 1, 2011 308
Australian Market Report of February 21, 2011: Prima BioMed (ASX:PRR) To Commence Clinical Trial For Ovarian Cancer Immunotherapy Vaccine. Feb 21, 2011 333
For the Treatment of Ovarian Cancer, Pegylated Liposomal Doxorubicin/Carboplatin Will Replace Paclitaxel/Carboplatin as the Standard Second-Line Treatment for Platinum Sensitive Patients. Dec 8, 2010 792
Cancer drug developer Exelixis Inc (South San Francisco CA) said interim data from two mid-stage trials of an experimental drug showed promise in patients with a type of prostate cancer and ovarian cancer, sending its shares up 31% for the week. Nov 22, 2010 471
Synta Announces Gynecologic Oncology Group (GOG) to Initiate Phase 2 Clinical Trial of Elesclomol for the Treatment of Ovarian Cancer. Nov 1, 2010 1497
Journal abstracts: metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner. Brief article Nov 1, 2010 250
Drug for ovarian cancer. Oct 12, 2010 125
New drug shows promise against platinum resistant ovarian cancer. Clinical report Oct 10, 2010 401
NICE declines to fund Yondelis for ovarian cancer treatment. Sep 20, 2010 130
Potential new target for treatment of ovarian cancer identified. Aug 17, 2010 362
New drug shows promise for ovarian cancer patients. Jul 1, 2010 176
About 48% of women with advanced ovarian cancer saw sustained benefits from treatment with Nektar Therapeutics Inc's (San Carlos CA) experimental drug NKTR-102 in a mid-stage study, the company said. Clinical report Jun 14, 2010 187
New drug may fight ovarian cancer. Jun 8, 2010 178
Tamoxifen found more effective, less toxic than thalidomide. Splete, Heidi Jun 1, 2010 478
Two Combination Treatment Regimens Added to Updated NCCN Guidelines for Ovarian Cancer. Jan 25, 2010 723
New gene may lead to personalized ovarian cancer treatment. Dec 9, 2009 290
Endocyte Presents Data on EC145 in Treatment of Ovarian Cancer Before the European Society of Gynaecologic Oncology. Oct 21, 2009 566
Townsend's New York observer: Dr. Stephen DeFelice starts clinical study combining carnitine and doxorubicin in treatment of advanced ovarian cancer. Cohen, Marcus A. Clinical report Aug 1, 2009 1968
Ovulation induction and cancer. Kent, Athol Brief article Aug 1, 2009 192
CA125 monitoring not beneficial in ovarian Ca. Dales, Mary Jo M. Report Jul 1, 2009 971
Ovarian cancer. Behr, Mary Case study Jul 1, 2009 605
The anticancer activity compared between triptorelin and a new gonadotropin releasing hormone analogue. Saleh-Abady, Mohammad Mirzaei; Alizadeh, Abdolali; Shamsipour, Fereshteh; Naderi-Manesh, Hossein Report Jul 1, 2009 2352
Research and Markets: Chinese Markets for Ovarian Cancer Treatment Drugs. May 12, 2009 159
Oasmia: FDA Grants Paclical(R) Orphan Drug Designation for Ovarian Cancer in the USA. Apr 14, 2009 487
Curis Announces Genentech's Initiation of Phase II Clinical Trial in Advanced Ovarian Cancer with Hedgehog Pathway Inhibitor. Dec 8, 2008 845
Insert Therapeutics to Initiate a Multinational Phase II Clinical Trial of Lead Drug Candidate IT-101 in Ovarian Cancer. Apr 17, 2008 758
Novel Akt Inhibitor VQD-002 Shown to Reverse Cisplatin Resistance in Ovarian Cancer. Jan 22, 2008 1066
Aethlon Medical Submits Ovarian Cancer Treatment Grant. Aug 7, 2007 720
BRITAIN: Hormone therapy breakthrough will help tackle ovarian cancer. Jun 15, 2007 379
Understand the benefits and risks of intraperitoneal therapy for advanced ovarian cancer. Oestreicher, Pamela Apr 1, 2007 1184
Cranberry juice promotes cancer-killing power of drugs. Sep 22, 2006 452
Ovarian Cancer Drug Combination Identified at Rational Therapeutics Receives FDA Approval; Researchers Utilized Human Tumor Microspheroid Platform to Identify Novel Platin Plus Gemcitabine Combination for Ovarian Cancer in 1995. Jul 28, 2006 463
LILLY (ELI) & COMPANY - FDA Approves Lilly's Gemzar For Ovarian Cancer Treatment. Jul 18, 2006 1138
Thalidomide aids topotecan efficacy in ovarian ca. Brunk, Doug May 15, 2006 583
Advaxis Continues Advancement of Two Listeria Vaccines Targeting Cancers Affecting Women. May 15, 2006 757
Drug Development Platform Utilizes Ex-Vivo Analysis of Human Tumor Spheroids; Ovarian Cancer Study Demonstrates EVA(TM) Assay Applications for Targeted Therapies. Apr 3, 2006 464
Old idea fights ovarian cancer. Brief Article Jan 28, 2006 265
European Commission Grants Orphan Drug Status for AmpliMed's Amplimexon(R) for the Treatment of Ovarian Cancer. Jan 11, 2006 621
Updated Clinical Studies Continue to Show Promise of OXiGENE's Drug Candidate, CA4P, for the Treatment of Advanced Ovarian Cancer. Nov 15, 2005 1250
Expression Genetics, Inc. Announces Enrollment of First Patients in Phase I Clinical Trial of Gene-Based IL-12 for Treatment of Ovarian Cancer. Oct 17, 2005 755
Ovarian Cancer; Treatment. Mar 16, 2005 2055
COX-2 inhibitors may protect against ovarian ca: small study. Johnson, Kate Brief Article Apr 1, 2004 250
Predicting response of ovarian cancer to paclitaxel treatment based on trend analysis of serum CA125. Nekulova, Mirka; Pecen, Ladislav; Kalabova, Renata; Simickova, Marta; Topolcan, Ondrej; Pikner, Rich Aug 1, 2002 2592
Low-malignancy ovarian ca therapy guidelines. (National Comprehensive Cancer Network). McNamara, Damian Brief Article May 1, 2002 739
Yew drug fights cancer. Seachrist, Lisa Brief Article Jan 13, 1996 194
PACLITAXEL EXTENDS LIFE OF OVARIAN CANCER PATIENTS May 22, 1995 694
Yew drugs show their mettle. Pennisi, Elizabeth Brief Article May 29, 1993 375
Cancer treatment uses 'suicide' gene. Travis, John Aug 3, 1991 390
Ovarian cancer vs. the spotted owl. Aug 1, 1991 642

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters